ReviewThe journal of venomous animals and toxins including tropical diseases2016
Endogenous phospholipase A
Review in The journal of venomous animals and toxins including tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 44 citations in OpenAlex.
- Nature's antivenom: Combinations of conserved rattlesnake serum metalloproteinase inhibitors block the lethal action of viper venoms.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Myotoxicity of Crotoxin on C2C12 Myoblasts and its Inhibition byCurrent protein & peptide science · 2025Article
- Proteomic diversity of Russell's viper venom: exploring PLA2 isoforms, pharmacological effects, and inhibitory approaches.Archives of toxicology · 2024Review
- Tissue damaging toxins in snake venoms: mechanisms of action, pathophysiology and treatment strategies.Communications biology · 2024Review
- One-Step Affinity Purification of Leucine-Rich αToxins · 2024Article
- Proteomics and life-history variability of Endogenous Phospholipases A2 Inhibitors (PLIs) in Bothrops jararaca plasma.PloS one · 2024Article
- Antileishmanial effects of γCdcPLI, a phospholipase A2 inhibitor from Crotalus durissus collilineatus snake serum, on Leishmania (Leishmania) amazonensis.Memorias do Instituto Oswaldo Cruz · 2023Article
- Orientational Preferences of GPI-Anchored Ly6/uPAR Proteins.International journal of molecular sciences · 2022Article
- Review
- Secreted Phospholipases AInternational journal of biological sciences · 2022Review
- Venom proteomic analysis of medically important Nigerian viperBiochemistry and biophysics reports · 2021Article
- BoaγPLI from Boa constrictor Blood is a Broad-Spectrum Inhibitor of Venom PLAJournal of chemical ecology · 2021Article
- Cytoplasmic Lipases-A Novel Class of Fungal Defense Proteins Against Nematodes.Frontiers in fungal biology · 2021Article
- Molecular Architecture of the Antiophidic Protein DM64 and its Binding Specificity to Myotoxin II FromFrontiers in molecular biosciences · 2021Article
- Identification and characterization of the first endogenous phospholipase AThe journal of venomous animals and toxins including tropical diseases · 2020Article
- Article
- Article
- Purification and characterization of the first γ-phospholipase inhibitor (γPLI) from Bothrops jararaca snake serum.PloS one · 2018Article
- Preparation of monoclonal antibodies against gamma-type phospholipase AThe journal of venomous animals and toxins including tropical diseases · 2017Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The blood plasma of numerous snake species naturally comprises endogenous phospholipase A
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.